# PT-141 Drug Interactions: 8 to Know Before You Start **By TelosRX Editorial Team** ยท 2026-10-02 **PT-141 drug interactions are limited but important. FDA labeling flags oral naltrexone, time-sensitive oral drugs, and blood pressure effects. [TelosRX](https://telosrx.com/pages/pt-141) walks through eight interactions to review with your provider before your first dose.** Most interaction lists read like a phone book. This one is short, because PT-141 doesn't tangle with many drugs. But the few that matter really matter. PT-141 is the research name for bremelanotide. As a brand, Vyleesi is FDA-approved for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). HSDD means persistent low desire that causes distress. Compounded PT-141 is **not FDA-approved**. Everything below draws on the [FDA prescribing information for Vyleesi](https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf) unless noted. Where the label is silent, we say so plainly. ## Why PT-141 Has Fewer Interactions Than Most Drugs **The liver isn't its main clearance route.** That single fact explains most of the short list. Many drug interactions happen in liver enzymes called CYP450. One drug slows those enzymes, and another drug builds up. Bremelanotide mostly sidesteps that system. The label describes its metabolism as multiple hydrolyses of the peptide's amide bonds. In plain English, enzymes snip the seven-amino-acid chain into pieces. Here's the rest of the profile at a glance: - **Peak level:** about 1 hour after injection - **Half-life:** about 2.7 hours (range 1.9 to 4.0) - **Bioavailability:** about 100% under the skin - **Protein binding:** about 21%, which is low - **Excretion:** roughly 65% in urine and 23% in feces So where do interactions come from? Mostly from two effects. PT-141 can slow stomach emptying, and it briefly raises blood pressure. Keep those two in mind. They explain most of the list below. ## PT-141 Drug Interactions at a Glance # Interaction Evidence level What labeling or research says 1 Oral naltrexone FDA label Avoid together; naltrexone exposure may drop significantly 2 Threshold-dependent oral drugs (e.g., antibiotics) FDA label Avoid PT-141 when taking them 3 Fast-acting oral pain relievers (e.g., indomethacin) FDA label Consider stopping PT-141 if relief is delayed 4 Blood pressure medicines and heart conditions FDA label (BP effect) Contraindicated with uncontrolled hypertension or known heart disease 5 Alcohol FDA label study No effect on PT-141 levels; some side effects shift 6 GLP-1 medications Not studied Overlapping nausea and slowed stomach emptying 7 Other melanocortin peptides Not studied Overlapping receptors and skin-darkening risk 8 ED drugs like sildenafil or tadalafil Not in label Combined blood pressure effects unknown Now the detail, one by one. ## 1\. Oral Naltrexone: The Clearest Warning **This is the interaction with the strongest label language.** PT-141 may significantly decrease how much oral naltrexone reaches your bloodstream. Naltrexone is used for alcohol use disorder and opioid use disorder. It's also an ingredient in some weight-management pills. If naltrexone levels fall, it may stop working as intended. The label says to avoid PT-141 with oral naltrexone products used for alcohol or opioid addiction. The reason given is the severe consequence of treatment failure. That's not a risk worth taking for any reason. What to do: tell your provider about any naltrexone product, including combination pills. Don't stop naltrexone on your own to make room for PT-141. ## 2\. Oral Drugs That Need a Minimum Blood Level Some medicines only work above a certain blood level. Doctors call this a threshold concentration. Antibiotics are the textbook example. Because PT-141 may slow gastric emptying, it can reduce the rate and extent of absorption of oral drugs. Gastric emptying is how fast food and pills leave your stomach. Slower emptying can blunt peak levels. The label's advice is direct. Avoid PT-141 while taking oral drugs that depend on threshold concentrations for efficacy. In practice, that often means pausing PT-141 during a course of antibiotics. Your provider and pharmacist can confirm what applies to your prescriptions. ## 3\. Fast-Acting Pain Relievers Like Indomethacin The same stomach-slowing effect matters when you want a drug to kick in quickly. In the label's drug interaction studies, indomethacin was one of two oral medicines affected to a clinically relevant degree. Naltrexone was the other. Indomethacin is an anti-inflammatory pain reliever. The label suggests considering stopping PT-141 if a quick-onset oral drug seems delayed. What does that look like day to day? If you rely on a fast oral pain reliever for migraines or flare-ups, mention it. Timing doses apart may be part of the plan, subject to your provider's review. Worth knowing: the label notes other tested oral medicines were **not** affected to a clinically relevant degree. This is a targeted caution, not a ban on all pills. ## 4\. Blood Pressure Medicines and Heart Conditions **PT-141 briefly raises blood pressure after each dose.** In clinical studies, systolic pressure rose by up to 6 mmHg and diastolic by up to 3 mmHg. Peaks came 2 to 4 hours after dosing. Heart rate dipped by up to 5 beats per minute at the same time. Both usually returned to baseline within 12 hours. Because of that effect, the label contraindicates PT-141 in two groups: - People with **uncontrolled high blood pressure** - People with **known cardiovascular disease** It also isn't recommended for people at high risk of heart disease. The label advises making sure blood pressure is well-controlled before starting. What about blood pressure medications? The label doesn't list a specific drug-to-drug interaction with them. But needing them is itself important context. Your provider will want your current readings and medication list before any approval. **Thinking about PT-141?** Learn how the [PT-141 program at TelosRX](https://telosrx.com/pages/pt-141) works. You complete an asynchronous intake online, including your medication list. Any prescription is subject to medical approval by a licensed provider. ## 5\. Alcohol: Less Interaction Than You'd Expect Good news for anyone who enjoys a glass of wine with dinner. Alcohol didn't change how the body handles bremelanotide in the label's study. That study gave 24 healthy adults a higher intranasal bremelanotide dose with or without alcohol. The alcohol dose was about three drinks for a 70 kg adult. The findings were mixed but reassuring: - Alcohol had **no effect** on bremelanotide blood levels. - Flushing was similar to bremelanotide alone. - Headache was more common than with bremelanotide alone, but similar to alcohol alone. - Drops in standing blood pressure were similar to alcohol alone. Still, alcohol adds its own dizziness and nausea. Moderation is the sensible default. We cover the details in [PT-141 and alcohol](https://telosrx.com/blogs/glp1/pt-141-alcohol-and-pt-141). ## 6\. GLP-1 Medications Like Semaglutide or Tirzepatide **This combination hasn't been formally studied.** So any guidance here is based on how the two drug types work. Both PT-141 and GLP-1 medications can slow stomach emptying. Both commonly cause nausea. In Vyleesi's phase 3 trials, 40% of users reported nausea. It usually started within an hour of dosing and lasted about two hours. Stacking two nausea-prone drugs may make stomach upset more likely. Slowed emptying from both could also compound the absorption issues described above. None of this means the pairing is off-limits. It means your provider should know about both. Dose timing and anti-nausea planning may come up during the review. ## 7\. Other Melanocortin Peptides, Including Melanotan II PT-141 works on melanocortin receptors in the brain. Melanocortin receptors are signaling switches tied to desire, appetite, and skin pigment. Melanotan II, a tanning peptide sold online, hits the same receptor family. No studies have tested these together. But overlapping receptor activity raises two concerns: - **Skin darkening.** The label reports focal hyperpigmentation in 1% of trial users on up to eight doses a month. In a separate study with daily dosing for eight days, 38% developed it. - **Stacked side effects.** More nausea, flushing, and blood pressure changes are plausible. Melanotan II is not FDA-approved for any use in people. Our clinical team advises against combining it with PT-141. ## 8\. ED Medications Like Sildenafil or Tadalafil This is one of the most searched questions about PT-141. The honest answer is that the Vyleesi label doesn't address it. Vyleesi is approved only for premenopausal women. It is not indicated for men or to enhance sexual performance. So the label's studies didn't focus on PDE5 inhibitors like sildenafil or tadalafil. The two drug types act differently. PDE5 inhibitors work on blood flow. PT-141 works through brain signaling. PDE5 inhibitors can lower blood pressure, while PT-141 briefly raises it. How those effects combine hasn't been studied in labeling. If you take or plan to take an ED medication, list it on your intake. Your provider will weigh it along with your heart health and blood pressure. ## Organ Function: A Different Kind of Interaction Your kidneys and liver can change how much PT-141 stays in your system. That's not a drug interaction, but it works like one. Condition Change in PT-141 exposure (AUC) Label guidance Mild kidney impairment About 1.2-fold higher No dose adjustment Moderate kidney impairment About 1.5-fold higher No dose adjustment Severe kidney impairment About 2-fold higher Use with caution Mild liver impairment About 1.2-fold higher No dose adjustment Moderate liver impairment About 1.7-fold higher No dose adjustment Severe liver impairment Not studied Use with caution AUC is total drug exposure over time. Higher exposure may mean more nausea or vomiting. Recent kidney and liver labs help your provider make a safer call. ## Dosing Rules That Lower Interaction Risk Some label rules exist partly to limit blood pressure effects. They're worth knowing even if you take nothing else. 1. **No more than one dose in 24 hours.** Extra doses within a day weren't studied for benefit and may add to blood pressure effects. 2. **No more than eight doses a month.** More frequent use raises hyperpigmentation risk and time spent with raised blood pressure. 3. **Dose ahead of time.** The label specifies at least 45 minutes before anticipated sexual activity. Your own protocol, including any compounded dose, is set by your provider. Our [PT-141 dosage guide](https://telosrx.com/blogs/peptides/pt-141-dosage-guide) explains what clinical research used. ## How to Prepare a Medication List for Your Provider **A complete list is your best defense against surprises.** Before your intake, gather the following: - Every prescription, with dose and timing - Over-the-counter pain relievers and sleep aids - Any naltrexone, including combination weight-loss pills - GLP-1 injections or pills - Peptides bought elsewhere, including tanning peptides - Supplements, including herbal products - Your latest home blood pressure readings Then compare notes with a pharmacist. Pharmacists catch interaction issues that busy prescribers sometimes miss. Update the list whenever something changes. A new antibiotic, a short course of steroids, or a new supplement all count. It takes two minutes and can save a lot of guesswork. Want the full side-effect picture too? See [what trials reported about PT-141 side effects](https://telosrx.com/blogs/peptides/pt-141-side-effects-safety). ## Signs an Interaction May Be Happening Most interactions are caught on paper before the first dose. Still, it helps to know what to watch for afterward. - **A regular medicine seems weaker or slower.** This may point to absorption effects. - **Nausea is stronger than expected.** This is more likely when stacking nausea-prone drugs. - **Headache, pounding heartbeat, or dizziness** after a dose may relate to blood pressure shifts. - **New dark patches** on the face, gums, or chest are worth reporting. With an asynchronous service, you can message your provider when something feels off. Don't wait for a scheduled check-in. For chest pain or severe symptoms, seek emergency care right away. ## What the Phase 3 Trials Add The safety data behind these warnings comes largely from RECONNECT. That was two identical 24-week trials in 1,247 premenopausal women with HSDD. The results were published in [Obstetrics & Gynecology in 2019](https://pubmed.ncbi.nlm.nih.gov/31599840/). Nausea, flushing, and headache were the most common side effects. In the label's pooled data, 8% of users stopped early because of nausea. Those trials were designed around one population and one brand product. Results may differ for other people and for compounded versions. That's one more reason a provider review comes first. ## Frequently Asked Questions ### Can you take PT-141 with naltrexone? FDA labeling says to avoid PT-141 with orally administered naltrexone products used for alcohol or opioid addiction. PT-141 may significantly lower naltrexone levels in the blood, which could make it less effective. Tell your provider about any naltrexone product, including combination weight-loss pills, before starting. ### Can you drink alcohol on PT-141? In the label's study, alcohol did not change bremelanotide blood levels. Flushing rates were similar to PT-141 alone. Headache was more common than with PT-141 alone, though similar to alcohol alone. Alcohol can add dizziness and nausea, so moderation is the sensible approach. Discuss your drinking habits with your provider. ### Does PT-141 interact with blood pressure medication? The FDA label doesn't list a specific interaction with blood pressure drugs. But PT-141 briefly raises blood pressure after each dose. It is contraindicated in uncontrolled hypertension and known cardiovascular disease. If you take blood pressure medication, your provider will review your readings before any approval. ### Can you take PT-141 with semaglutide or tirzepatide? This combination hasn't been formally studied. Both drug types can slow stomach emptying and cause nausea, so side effects may stack. That doesn't automatically rule it out. Your provider should know about both medications and may plan dose timing or anti-nausea support. Approval is subject to provider review. ### Can PT-141 be taken with Viagra or Cialis? The Vyleesi label does not address PDE5 inhibitors like sildenafil or tadalafil. Vyleesi is approved only for premenopausal women with HSDD, not for men. The combined blood pressure effects haven't been studied. List any ED medication on your intake so a licensed provider can assess your heart health first. ### Does PT-141 affect birth control? The FDA label advises using effective contraception while taking Vyleesi, based on animal reproduction data, and stopping it if pregnancy is suspected. PT-141 may also slow stomach emptying, which can affect how some oral drugs are absorbed. Ask your provider or pharmacist whether dose timing matters for your specific contraceptive. _TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._ Start your private evaluation at [TelosRX](https://telosrx.com). **Tags:** bremelanotide, listicle, PT-141, PT-141 drug interactions, PT-141 safety, sexual wellness peptides --- > Source: [Telos RX](https://www.telosrx.com/blogs/peptides/pt-141-drug-interactions)